CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Eps Summary of CStone Pharmaceuticals

  • CStone Pharmaceuticals's latest annual eps in 2023 was -0.29 CNY , up 64.63% from previous year.
  • CStone Pharmaceuticals's latest quarterly eps in 2024 Q1 was 0.01 CNY , up 108.06% from previous quarter.
  • CStone Pharmaceuticals reported an annual eps of -0.82 CNY in 2022, up 52.05% from previous year.
  • CStone Pharmaceuticals reported an annual eps of -1.71 CNY in 2021, down -46.15% from previous year.
  • CStone Pharmaceuticals reported a quarterly eps of 0.01 CNY for 2024 Q1, up 108.06% from previous quarter.
  • CStone Pharmaceuticals reported a quarterly eps of N/A for 2023 FY, up 64.63% from previous quarter.

Annual Eps Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Eps of CStone Pharmaceuticals (2023 - 2016)

Year Eps Eps Growth
2023 -0.29 CNY 64.63%
2022 -0.82 CNY 52.05%
2021 -1.71 CNY -46.15%
2020 -1.17 CNY 66.86%
2019 -3.53 CNY -97.21%
2018 -1.79 CNY -459.38%
2017 -0.32 CNY -28.0%
2016 -0.25 CNY 0.0%

Peer Eps Comparison of CStone Pharmaceuticals

Name Eps Eps Difference
Uni-Bio Science Group Limited 0.01 HKD 2712.613%
CK Life Sciences Int'l., (Holdings) Inc. 0.00 HKD 16211.111%